PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663540
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663540
Hysterectomy Device Market size was valued at US$ 351.2 Million in 2024, expanding at a CAGR of 6.20% from 2025 to 2032.
Hysterectomy devices are medical equipment used to remove the uterus surgically. Common gynaecological procedures include hysterectomies, and the instruments used in these operations can differ according to the kind of surgery done. This can be done for a number of reasons, including treating certain cancers or gynaecological disorders such as endometriosis, uterine fibroids, and irregular uterine flow. There are several surgical methods available for performing hysterectomies, such as laparoscopic surgery, open surgery, and robotic-assisted surgery. The growing prevalence of gynaecological disorders, the growing demand for minimally invasive surgical techniques, and technological advancements like the introduction of robot-assisted and minimally invasive hysterectomy procedures are some of the factors driving the market for hysterectomy devices. Additionally, as more individuals have access to high-quality medical care and procedures, the market for hysterectomy devices is anticipated to develop as a result of the expansion of healthcare facilities. It is anticipated that the expansion of the healthcare infrastructure will lead to an increase in the need for medical supplies and equipment, particularly hysterectomy devices, which will fuel the industry's expansion.
Hysterectomy Device Market- Market Dynamics
Rising Prevalence of Obesity
The percentage of children and adolescents aged 5 to 19 who are overweight or obese has increased dramatically, from around 4% in 1975 to a little over 18% in 2016. Obesity rates among children and adolescents aged 5 to 19 increased from less than 1% in 1975 to over 124 million in 2016. Women are also more likely than males to be obese (40%), and obesity has a significant negative influence on women's health in a number of different ways. Therefore, the rising rate of obesity in women is anticipated to lead to problems such as fibroids, uterine cancer, or persistent pelvic pain, which will raise the need for hysterectomies and accelerate the expansion of the hysterectomy device market.
Hysterectomy Device Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.20% over the forecast period (2025-2032)
Based on surgical approach segmentation, the abdominal hysterectomy was predicted to show maximum market share in the year 2024
Based on end-use segmentation, ambulatory surgical centers were the leading segment in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Hysterectomy Device Market is segmented on the basis of Surgical Approach, Disease, End Use, and Region.
On the basis of disease, the market is segregated into Uterine Cancer, Chronic pelvic pain, Fibroids, and Others. In 2024, the market was dominated by the chronic pelvic pain category. This is due to the fact that it is a crippling, chronic, and ongoing ache in a woman's pelvis. Comorbidities such as pelvic inflammatory disease, major depressive illness, or irritable bowel syndrome are often associated with chronic pelvic discomfort. There are a number of possible causes for the complex condition known as persistent pelvic discomfort.
Based on end use, the market is divided into Hospitals, Clinics, Ambulatory Surgical Centers, and Others. In 2024, the ambulatory surgical centres category held a dominant market share. Numerous causes are responsible for the growth, such as the growing demand for outpatient care, the rise in minimally invasive operations, and the low cost of laparoscopic procedures carried out in ambulatory surgical clinics. The decreased risk of postoperative problems associated with minimally invasive laparoscopic surgery is expected to increase demand for mobile surgery facilities.
Hysterectomy Device Market- Geographical Insights
In 2024, North America held a dominant position in the global market for Hysterectomy Device. This is because of a number of important players and regional technological advancements. In acquisition tactics, these major stakeholders are crucial. Additionally, it is projected that the region's robust consumer base, buying power, established healthcare infrastructure, and rising uterine cancer prevalence will support the growth of the hysterectomy device market. Furthermore, the region's rising uterine cancer prevalence is anticipated to fuel market expansion. High buying power and the existence of a well-established healthcare infrastructure are also anticipated to propel market expansion. In addition, the market's expansion is aided by acquisitions made by the major competitors in this area.
However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. The existence of pharmaceutical businesses in the area and the rise in the purchasing power of populous nations like China and India are responsible for the market expansion in this region. Furthermore, because of the expanding industrial infrastructure, rising disposable incomes, and established domestic companies in the region, Asia-Pacific offers lucrative opportunities for major players in the hysterectomy device market, registering the fastest growth rate during the forecast period. Additionally, the growing number of contract manufacturing companies in the area offers excellent prospects for newcomers.
There are several competitors in the very competitive hysterectomy device market, both domestically and internationally, such as ConMed Corporation, Medtronic PLC, B.Braun Melsungen AG, Karl Storz SE & Co. KG, The Cooper Companies, Inc., and others. Prominent providers of surgical instruments, healthcare facilities, and manufacturers of medical devices are important market participants. To improve their market position, these businesses concentrate on product development, strategic alliances, mergers and acquisitions, and global expansion. For instance, in February 2022, Cook Medical's Reproductive Health Business, which produces minimally invasive medical devices for the obstetrics, fertility, and gynaecologist markets, agreed to be acquired by CooperCompanies. The acquisition would increase the former company's global fertility footprint and add delivery devices to its ObGyn portfolio.
Recent Development
February 2023: Novonate's LifeBubble technology, which raises the fetus' head to facilitate a less stressful and easier birth for both mother and child, was acquired by Laborie. The businesses are working together to raise the bar for neonates receiving critical care.
November 2022: The TruClear system, a mechanical hysteroscopic tissue removal method for the effective and secure treatment of intrauterine abnormalities (IUA), was introduced by Medtronic Private Limited, a part of Medtronic PLC. Instead of using a high-frequency electric current, the TruClear device manually removes intrauterine tissue, in contrast to other intrauterine abnormality therapy techniques. The goal of the technology is to make it easier to treat intrauterine diseases in a less intrusive and effective way, allowing patients to keep the organ and quickly resume their normal lives.
September 2022: The first gynaecological (hysterectomy) procedure in Asia Pacific was introduced by Medtronic and CARE Hospitals Group, utilizing the Hugo robotic-assisted surgery (RAS) system. Making investments in technology-enabled healthcare solutions is crucial to providing patients with high-quality care at affordable costs. Superior equipment, such as a robotic system, helps to increase accuracy, reduce hospital stays, and expedite patient recovery.